Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Bionano Genomics Inc (NASDAQ: BNGO) was $0.23 for the day, down -0.31% from the previous closing price of $0.23. In other words, the price has decreased by -$0.31 from its previous closing price. On the day, 6.88 million shares were traded. BNGO stock price reached its highest trading level at $0.2359 during the session, while it also had its lowest trading level at $0.21.
Ratios:
Our analysis of BNGO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.99 and its Current Ratio is at 1.43. In the meantime, Its Debt-to-Equity ratio is 0.46 whereas as Long-Term Debt/Eq ratio is at 0.11.
On January 05, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $4.Scotiabank initiated its Sector Outperform rating on January 05, 2023, with a $4 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BNGO now has a Market Capitalization of 31684120 and an Enterprise Value of 30635666. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.95 while its Price-to-Book (P/B) ratio in mrq is 0.41. Its current Enterprise Value per Revenue stands at 0.838 whereas that against EBITDA is -0.335.
Stock Price History:
The Beta on a monthly basis for BNGO is 2.22, which has changed by -0.82170546 over the last 52 weeks, in comparison to a change of 0.22263205 over the same period for the S&P500. Over the past 52 weeks, BNGO has reached a high of $1.79, while it has fallen to a 52-week low of $0.19. The 50-Day Moving Average of the stock is -9.57%, while the 200-Day Moving Average is calculated to be -60.22%.
Shares Statistics:
BNGO traded an average of 6.77M shares per day over the past three months and 26156210 shares per day over the past ten days. A total of 139.82M shares are outstanding, with a floating share count of 139.11M. Insiders hold about 0.51% of the company’s shares, while institutions hold 3.90% stake in the company. Shares short for BNGO as of 1730332800 were 9828723 with a Short Ratio of 2.61, compared to 1727654400 on 6068844. Therefore, it implies a Short% of Shares Outstanding of 9828723 and a Short% of Float of 10.26.
Earnings Estimates
The dynamic stock of Bionano Genomics Inc (BNGO) is currently attracting attention from 1.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.14 and low estimates of -$0.14.
Analysts are recommending an EPS of between -$1.01 and -$1.01 for the fiscal current year, implying an average EPS of -$1.01. EPS for the following year is -$0.48, with 2.0 analysts recommending between -$0.45 and -$0.51.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 3 analysts. It ranges from a high estimate of $6.5M to a low estimate of $6M. As of the current estimate, Bionano Genomics Inc’s year-ago sales were $10.72MFor the next quarter, 3 analysts are estimating revenue of $8.15M. There is a high estimate of $12.46M for the next quarter, whereas the lowest estimate is $6M.
A total of 3 analysts have provided revenue estimates for BNGO’s current fiscal year. The highest revenue estimate was $29.11M, while the lowest revenue estimate was $28.6M, resulting in an average revenue estimate of $28.9M. In the same quarter a year ago, actual revenue was $36.12MBased on 4 analysts’ estimates, the company’s revenue will be $36.57M in the next fiscal year. The high estimate is $54.19M and the low estimate is $27.5M.
